Inventor · disambiguated record
Vincent S. Madison
Also filed as: MADISON VINCENT · MADISON VINCENT S · MADISON VINCENT STEWART
45 granted patents·8 pending applications·654 citations·filing 1987–2011
98Inventor score
Top patents by PatentIndex Score
53 records- 0195US7488745B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2007·Granted Feb 10, 2009·23 cites·34 claims
- 0295US6846802B2Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moietiesSCHERING CORP·Filed 2001·Granted Jan 25, 2005·124 cites·21 claims
- 0394US6914122B2Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moietiesSCHERING CORP·Filed 2001·Granted Jul 5, 2005·89 cites·36 claims
- 0493US7807672B2Compounds that are ERK inhibitorsSCHERING CORP·Filed 2007·Granted Oct 5, 2010·16 cites·23 claims
- 0592US7504424B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2006·Granted Mar 17, 2009·24 cites·3 claims
- 0692US6894072B2Compounds as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2003·Granted May 17, 2005·59 cites·25 claims
- 0791US7482370B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2005·Granted Jan 27, 2009·20 cites·79 claims
- 0891US7119200B2Pyrazolopyrimidines as cyclin dependent kinase inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2004·Granted Oct 10, 2006·45 cites·13 claims
- 0988US7879890B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Feb 1, 2011·6 cites·11 claims
- 1088US7161003B1Pyrazolopyrimidines as cyclin dependent kinase inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted Jan 9, 2007·32 cites·31 claims
- 1187US7968683B1Factor IXa crystals, related complexes and methodsSCHERING CORP·Filed 2009·Granted Jun 28, 2011·7 cites·16 claims
- 1286US8546404B2Compounds that are ERK inhibitorsCOOPER ALAN B·Filed 2007·Granted Oct 1, 2013·9 cites·76 claims
- 1386US7687527B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Mar 30, 2010·8 cites·9 claims
- 1485US8673924B2Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitorsGUZI TIMOTHY J·Filed 2007·Granted Mar 18, 2014·11 cites·25 claims
- 1584US7683085B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Mar 23, 2010·6 cites·10 claims
- 1682US7638513B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2005·Granted Dec 29, 2009·6 cites·5 claims
- 1780US7700773B24-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1,5-a]pyridines, pyrazolo[1,5-c]pyrimidines and 2H-indazole compounds and 5-cyano, 5-amino, and 5-aminomethyl derivatives of imidazo[1,2-a]pyridines, and imidazo[1,5-a]pyrazines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2006·Granted Apr 20, 2010·3 cites·20 claims
- 1880US5298652AN-substituted glycines, inhibitors of phospholipase A2HOFFMANN LA ROCHE·Filed 1992·Granted Mar 29, 1994·19 cites·19 claims
- 1977US7208311B2Catalytic domain of ADAM33 and methods of use thereofSCHERING CORP·Filed 2003·Granted Apr 24, 2007·4 cites·10 claims
- 2076US7776589B1Polynucleotides encoding polypeptide fragments of protein kinase B gamma (AKT3)SCHERING CORP·Filed 2007·Granted Aug 17, 2010·2 cites·8 claims
- 2175US7553864B2Compounds for the treatment of inflammatory disorders and microbial diseasesSCHERING CORP·Filed 2006·Granted Jun 30, 2009·2 cites·14 claims
- 2273US5374772ASubstituted benzoic acids, inhibitors of phospholipases A2HOFFMANN LA ROCHE·Filed 1993·Granted Dec 20, 1994·29 cites·30 claims
- 2373US4808701ACyclic peptides having appetite regulating activityHOFFMANN LA ROCHE·Filed 1987·Granted Feb 28, 1989·18 cites·16 claims
- 2472US7514442B2Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2006·Granted Apr 7, 2009·1 cites·12 claims
- 2572US7067661B2Pyrazolopyrimidines as cyclin dependent kinase inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted Jun 27, 2006·5 cites·21 claims
- 2671US8710188B2Factor IXa crystals, related complexes and methodsBEYER BRIAN M·Filed 2011·Granted Apr 29, 2014·1 cites·5 claims
- 2771US5084442ACyclic growth hormone releasing factor analogs and method for the manufacture thereofHOFFMANN LA ROCHE·Filed 1988·Granted Jan 28, 1992·42 cites·23 claims
- 2868US7335758B2Catalytic domain of ADAM33 and methods of use thereofSCHERING CORP·Filed 2006·Granted Feb 26, 2008·0 cites·11 claims
- 2966US8034907B2Polynucleotides encoding soluble, stable forms of human double minute 2 polypeptidesSCHERING CORP·Filed 2009·Granted Oct 11, 2011·0 cites·7 claims
- 3066US5324747AN-substituted anilines, inhibitors of phospholipases A2HOFFMANN LA ROCHE·Filed 1992·Granted Jun 28, 1994·18 cites·44 claims
- 3165US8088611B2Kinase domain polypeptide of human protein kinase B gamma (AKT3)PRONGAY ANDREW J·Filed 2010·Granted Jan 3, 2012·1 cites·5 claims
- 3263US7705127B1HDM2 PolypeptidesSCHERING CORP·Filed 2008·Granted Apr 27, 2010·0 cites·8 claims
- 3362US5446189AIntermediates for the production of N-substituted anilines, inhibitors of phospholipases A2HOFFMANN LA ROCHE·Filed 1994·Granted Aug 29, 1995·13 cites·4 claims
- 3461US7824491B2Method for crystallizing aurora 2 kinase catalytic domain polypeptideSCHERING CORP·Filed 2008·Granted Nov 2, 2010·0 cites·5 claims
- 3561US7422885B1Crystalline form of the catalytic domain of Aurora 2 kinase and methods of use thereofSCHERING CORP·Filed 2004·Granted Sep 9, 2008·0 cites·3 claims
- 3660US7285408B2Crystalline form of an n231 mutant catalytic domain of ADAM33 and methods of use thereofSCHERING CORP·Filed 2003·Granted Oct 23, 2007·0 cites·8 claims
- 3760US2008199447A1Catalytic domain of adam33 and methods of use thereofSCHERING CORP·Filed 2007·Application pending·0 cites
- 3858US7632920B2Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereofSCHERING CORP·Filed 2004·Granted Dec 15, 2009·0 cites·10 claims
- 3957US7807683B2N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2006·Granted Oct 5, 2010·0 cites·11 claims
- 4056US7785879B1Pregnane X receptor compositions, crystals and uses thereofSCHERING CORP·Filed 2006·Granted Aug 31, 2010·0 cites·16 claims
- 4156US5013722ACholecystokinin analogs for controlling appetiteHOFFMANN LA ROCHE·Filed 1989·Granted May 7, 1991·11 cites·22 claims
- 4252US7888474B2HDM2 polypeptidesSCHERING CORP·Filed 2010·Granted Feb 15, 2011·0 cites·8 claims
- 4352US2007054925A1Novel pyrazolopyrimidines as cyclin dependent kinase inhibitorsPHARMACOPEIA INC·Filed 2006·Application pending·0 cites
- 4450US8048663B2Crystal of pregnane X receptor fused to steroid receptor coactivator-1SCHERING CORP·Filed 2010·Granted Nov 1, 2011·0 cites·7 claims
- 4550US2010074867A1P1-nonepimerizable ketoamide inhibitors of hcv ns3 proteaseSCHERING CORP PATENT DEPARTMEN·Filed 2008·Application pending·0 cites
- 4649US2010143384A1NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES AS CYCLIN DEPENDENT KINASE INHIBITORSMALLAMS ALAN K·Filed 2010·Application pending·0 cites
- 4749US2007167426A1Compounds for the treatment of inflammatory disorders and microbial diseasesSCHERING CORP·Filed 2006·Application pending·0 cites
- 4849US2010137326A1NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES AS CYCLIN DEPENDENT KINASE INHIBITORSSCHERING CORP·Filed 2010·Application pending·0 cites
- 4948US8440443B1MEK1 polypeptidesFISCHMANN THIERRY O·Filed 2007·Granted May 14, 2013·0 cites·4 claims
- 5048US7511063B2High affinity quinoline-based kinase ligandsSCHERING CORP·Filed 2006·Granted Mar 31, 2009·0 cites·51 claims
Showing the top 50 of 53 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →